Review paper Effect of multifactorial therapy of metabolic syndrome on the prevalence of late complications of type 2 diabetes

Anna Poradzka; Mariusz Jasik; Waldemar Karnafel; Piotr Fiedor

eISSN: 2084-9877
ISSN: 1896-9666

Przegląd Kardiodiabetologiczny/Cardio-Diabetological Review

Current issue Archive About the journal Abstracting and indexing Contact Instructions for authors

3/2011
vol. 6

Send email

Copy url:

abstract:

Review paper
Effect of multifactorial therapy of metabolic syndrome on the prevalence of late complications of type 2 diabetes

Anna Poradzka

,

Mariusz Jasik

,

Waldemar Karnafel

,

Piotr Fiedor

Przegląd Kardiodiabetologiczny 2011; 6 (3): 213–219

Online publish date: 2011/10/07

View full text Get citation

The metabolic syndrome is one of the main world health problems. It causes increased cardiovascular risk and, as a result, increased mortality. It consists of enlarged waist circumference, elevated triglycerides, lowered HDL cholesterol, and elevated blood pressure and fasting glucose. It is easy to examine the majority of components in routine clinical practice, which makes diagnosis of the metabolic syndrome possible. Treatment of the metabolic syndrome components influences complications of type 2 diabetes profitably. This work briefly describes the ways of management of obesity, dyslipidaemia and hypertension, as well as antiplatelet agents and their importance in lowering the risk of occurrence of diabetic complications.

keywords:

Review paperEffect of multifactorial therapy of metabolic syndrome on the prevalence of late complications of type 2 diabetes

Anna Poradzka , Mariusz Jasik , Waldemar Karnafel , Piotr Fiedor

metabolic syndrome, type 2 diabetes, late complications of diabetes

Review paper
Effect of multifactorial therapy of metabolic syndrome on the prevalence of late complications of type 2 diabetes

Anna Poradzka

,

Mariusz Jasik

,

Waldemar Karnafel

,

Piotr Fiedor